progressive aesthetic learning essential to technical expertise®

The Artistry and Technique of Facial Rejuvenation Online CME Post-Test

Full Name: Degree: e-mail:

May we contact you in approximately three months to determine if you were able to implement changesin your practice as a result of this CME activity?

Yes, contact my by email Yes, contact me by fax No, do not follow up

1. A reference line used to assess anteroposterior positioning in the lower face, which is runs from lower lip to chin is called:

Ricketts line

Holdaway line

Burstone line

Steiner line

2. To correct volume loss, concavity, and shadowing along the inferolateral orbital rim, �ller should be injected deep to which fat pad?

Lateral fat pad

Buccal fat pad

Lateral suborbicularis oculi fat (SOOF) fat pad

Temporal fat pad

3. Volumization of the chin will:

Provide extra anterior projection of the chin.

Ovalize the face in anterior view.

Elongate the jawline in lateral (pro�le) view

All of the above

Post-test Questions for Case 1: 63-year-old ballet dancer

Post-test Questions for for the Case 2: 61-year-old male

4. Which of the following is NOT true concerning genderspeci�c considerations for panfacial rejuvenation?

Glabellar doses of neuromodulator are usually higher in men compared to doses in women because of greater muscle bulk

When placing dermal �ller in the midface, it is important to remember that the apex of a man’s cheek should be more inferolateral than in a woman.

A woman’s brows should appear more horizontal and low set compared to a man’s.

The overall shape of a man’s face should be more angular and square, while a woman’s should be relatively more heartshaped.

Post-test Questions for for the Case 2: 61-year-old male (cont)

Post-test question for: “TOXIN TECHNIQUES: AVOIDING AND MANAGING COMPLICATIONS”

Post-test question for: “FILLERS: ADVANCED AREA: NASAL AUGMENTATION”:

Post-test questions for “FILLERS: AVOIDING AND MANAGING COMPLICATIONS”

5. When performing nonsurgical facial rejuvenation with injectable agents, the risk of complication can be minimized by?

Avoiding the super�cial dermis plane and the deep superperiosteal plane when injecting dermal �ller into the glabella.

Injecting neuromodulator into depressor labii muscles rather than into the mentalis muscle for the correction of lower face “dimpling.”

Using cannula technique for nasolabial injections of dermal �ller which can avoid the angular artery.

All of the above

6. Which of the following is true concerning treatment with HA dermal �llers?

A lidocaine containing dermal �ller should not be used if topical anesthetic is applied

Dermal �llers should always be placed as deeply as possible to achieve the “smoothest” result.

Reconstitution with bacteriostatic saline yields a more viscous product desirable for certain anatomic areas.

Correction of one anatomic area may accentuate loss in another area

7. If lid ptosis occurs as a complication of neuromodulator injection:

Inject hyaluronidase to reverse the drug e�ect

Advise patient that neuromodulator can never be injected again

Alpha-adrenergic ophthalmic drops can be a helpful treatment

None of the above

8. Which is a true statement concerning nasal dorsum augmentation:

A hyaluronic acid dermal �ller is the preferred product

The procedure is most successful in patients with prior rhinoplasty

High volumes of �ller are required

Patients should be instructed to massage area frequently during �rst 24 hours post procedure

9. Which of the following techniques can help reduce the risk of ischemic complication?

Rapid injection of product

Injection using cannula

Injection parallel to known vasculature

All of the above

Post-test questions for “FILLERS: AVOIDING AND MANAGING COMPLICATIONS” (cont)

10. Injection of hyaluronidase:

E�ectively dissolves all types of dermal �llers

Can be performed only once

Is most bene�cial is very small doses

None of the above

Post-test question for: “CLINICAL CONSIDERATIONS: THE IMPORTANCE OF A MEDICAL HISTORY”

11. Which of the following is true concerning importance of medical history?

A defect resulting from Mohs surgery is not correctable with dermal �ller

Acute infection or in�ammation may be a reason to postpone facial injections

Dermal �llers are contraindicated in patients with facial implants

All of the above

The Artistry and Technique of Facial Rejuvenation CME Evaluation Form Albert Einstein College of Medicine and Montefiore Medical Center, and Scientiae, LLC are committed to excellence in continuing education. Your opinions are critical to us in this e�ort. To assist us in evaluating the e�ectiveness of this activity and to make recommendations for future educational o�erings, please re�ect carefully and complete this evaluation form.

Please note: a CME Certi�cate is issued only after the receipt of your completed evaluation form

progressive aesthetic learning essential to technical expertise®

I. Practice Demographics What is your degree?

MD DO DDS DMD NP PA RN

Degree Other:

Type of Practice:

Number of patients you see each week for the conditions addressed by this activity?

0 1 - 5 6 - 10 > 10

II. Learning ObjectivesHow well did this activity meet the following learning objectives

A. Describe anatomical changes associated with facial aging in order to best evaluate the clinical and cosmetic needs of patients

Excellent Good Fair Poor

B. Identify the optimal placement of injectable agents, in order to enhance the aesthetic appearance of the face and maximize treatment outcomes

Excellent Good Fair Poor

C. Recognize the anatomical relationship of critical vascular and neurologic structures within the face, in order to assure patient safety and avoid treatment complications

Excellent Good Fair Poor

III. Practice Changes you expect to make: State practice changes you are committed to making based on the activity objectives listed above:

Please indicate your level of agreement with this statement:

"This course will reduce the number of complications associated with nosurgical facial rejuvenationprocedures in my practice"

Strongly Agree Agree Disagree Not sure

As a result of this activity, has your con�dence/comfort level of injecting:

Increased a great deal Increased moderately Remained the same Decreased

IV. As a result of this activity, how much do you expect to improve in:

A. Educating your patients about the facial aging process, and how it a�ects treatment decisions regarding what areas of the face to treat?

1 - 10% 10 - 20% 21 - 30% 31 - 40% 41 - 50% 51 - 60%

61 - 70% 71 - 80% 81 - 90%

B. Managing your Patient’s expectations about aesthetic outcomes

1 - 10% 10 - 20% 21 - 30% 31 - 40% 41 - 50% 51 - 60%

61 - 70% 71 - 80% 81 - 90%

C. Educating patients and managing their expectations about possible complications due to injectable agents (botulinum toxin and dermal �llers)?

1 - 10% 10 - 20% 21 - 30% 31 - 40% 41 - 50% 51 - 60%

61 - 70% 71 - 80% 81 - 90%

D. Instructing your practice sta�/colleagues on management of complications?

1 - 10% 10 - 20% 21 - 30% 31 - 40% 41 - 50% 51 - 60%

61 - 70% 71 - 80% 81 - 90%

VI. What was the most e�ective aspect(s) of this activity, and why?

VII. What was the least e�ective aspect(s) of this activity?

VIII. Compared with all other CME activities I have participated in over the past year, I would rate this program as:

A model of its kind Above average Average Needs improvement

IX. Suggestions for any speci�c topics/clinical conditions that you would like covered in future educational activities, i.e. workshops, webcasts, web modules, etc.

X. If commercial bias was perceived, please specify:

XI. Additional comments are welcome:

If you have any issues you would like to discuss with the O�ce of Continuing Medical Education,please list your name and phone number below, and we will contact you. Thank you.

Please save this �le and submit to:info@paletteresources.com